You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

30 April 2015

Increased risk of HIV immediately following circumcision

Men who have undergone circumcision are at increased risk of infecting female partners with HIV immediately following surgery suggests research from the Johns Hopkins University and the Rakai Health Sciences Program in Uganda. Male circumcision is used as an HIV prevention method as it is known to reduce the of heterosexually acquired HIV infection in men by 60%.

0
21 April 2015

Should PrEP be rolled out worldwide?

Multiple randomised controlled trials have proven that the use of pre-exposure prophylaxis (PrEP) significantly reduces the risk of HIV among people at risk. Despite its proven efficacy, PrEP is not widely implemented as an HIV prevention tool. With nearly two million new HIV infections last year, it would seem that PrEP is being overlooked, as commented by a group of scientists in last week editions of The Lancet.

0
01 April 2015

OST positively affects treatment adherence for people who inject drugs

People living with HIV who inject drugs have a 68% increase in the odds of refilling their antiretroviral treatment (ART) prescriptions after being exposed to opioid substitution therapy (OST). The research, published ahead of print in the journal AIDS, gives further evidence to the benefits of OST, particularly for ART adherence.

0
13 March 2015

Primary care providers need further training on HIV

The introduction of pre-exposure prophylaxis (PrEP) for people at an increased risk of HIV is challenging healthcare providers. People newly infected with HIV will normally seek care from a doctor specialised in HIV, but for people who protect themselves from HIV through the use of antiretroviral medication (PrEP), they will normally engage with a primary care provider, and not a specialist.

0
25 February 2015

Pre-exposure prophylaxis (PrEP) 86% effective in reducing HIV among MSM

The use of antiretroviral treatment (ART) as a pre-exposure prophylaxis (PrEP) has been shown to be 86 percent effective in preventing new HIV infections among men who have sex with men (MSM), and 96 percent effective with serodifferent couples, when the HIV positive partner is also on ART.

0
09 January 2015

Use of injectable contraceptives increase risks of HIV

The use of injectable contraceptives moderately increases the risks of HIV in women, this is compared to other women who use other hormonal contraceptives, including the pill. The new research published in the Lancet Infectious Diseases, polled results from 12 observational trials. They concluded that woman at a higher risk of HIV infection, and using injectable contraceptives, had a 40 percent increased risk of HIV, will women of the general population have a 30 percent increased risk.

0